Oratoria (Dexamethasone Phosphate)

Dexamethasone phosphate, the active ingredient in Oratoria, is a corticosteroid presented as a sterile injectable solution for ophthalmic use. It treats inflammatory ocular conditions and is used in patients requiring anti‑inflammatory therapy in the eye.

GNH USA supplies Oratoria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and ophthalmology clinics worldwide.

Dexamethasone phosphate is a potent anti‑inflammatory corticosteroid that acts on ocular inflammatory pathways. - Post‑operative ocular inflammation: reduces swelling and pain after eye surgery. - Anterior uveitis: controls inflammation of the front part of the eye. - Allergic conjunctivitis: alleviates redness and itching caused by allergic reactions.

Adverse reactions may occur following ocular administration of dexamethasone phosphate.

Common Side Effects: - Increased intra‑ocular pressure: transient rise that may require monitoring. - Cataract formation: accelerated lens opacity with prolonged use. - Ocular irritation: stinging or burning sensation on instillation. - Blurred vision: temporary visual disturbance after dosing. - Conjunctival hyperemia: redness of the eye surface.

Serious or Rare Side Effects: - Secondary ocular infection: bacterial or fungal infection due to immunosuppression. - Glaucoma: sustained elevation of intra‑ocular pressure leading to optic nerve damage. - Vitreous hemorrhage: bleeding within the eye cavity. - Endophthalmitis: severe intra‑ocular infection requiring urgent treatment.

When using dexamethasone phosphate, clinicians should consider several safety measures. - Monitor intra‑ocular pressure: regular checks are essential, especially in glaucoma‑susceptible patients. - Limit duration of therapy: avoid prolonged use to reduce risk of cataract and pressure rise. - Assess for infection: ensure no active ocular infection before initiating therapy. - Use with caution in diabetics: systemic absorption may affect blood glucose control. - Store at below 25°C: keep in the original container, protect from light and moisture.

Dexamethasone phosphate may interact with other medications that influence intra‑ocular pressure or systemic corticosteroid exposure.

Major Interactions (Avoid): - Carbonic anhydrase inhibitors (e.g., dorzolamide): may exacerbate intra‑ocular pressure elevation. - Antifungal agents (e.g., ketoconazole): can increase systemic corticosteroid levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive anti‑inflammatory effect may mask infection signs. - Antidiabetic drugs: systemic absorption may require dose adjustment of insulin or oral hypoglycemics. - Antihistamines: may potentiate ocular drying, increasing discomfort.